NCPA has endorsed Arkansas H.B. 1801—a bill that would allow 503B outsourcing facilities to sell compounded drugs to 503A compounding pharmacies—because it provides 503A compounding pharmacies and patients alike in Arkansas with greater access to compounded drugs.
NCPA
